© 2021 MJH Life Sciences and Formulary Watch. All rights reserved.
© 2021 MJH Life Sciences™ and Formulary Watch. All rights reserved.
January 18, 2021
His vaccination plans includes a promise of setting up 100 federally support community vaccine sites in the first month of his administration.
January 13, 2021
AstraZeneca’s leading diabetes medication could be approved to treat chronic kidney disease for patients with and without type 2 diabetes.
January 12, 2021
New treatment for metastatic HER2-positive breast cancer is called Margenza.
January 06, 2021
Many pharmaceutical manufacturers are raising prices this year, but at a lower overall rate than in the past couple of years, according to a new analysis.
January 04, 2021
Amphastar Pharmaceuticals’ generic version will offer stiff competition to Eli Lilly’s Glucagon Emergency Kit for Low Blood Sugar.
December 22, 2020
The biosimilar to Rituxan is expected to erode market share of the mainstay cancer drug for Roche.
December 18, 2020
Orgovyx, the first oral drug in its class, may help reduce clinic visits for men with prostate cancer. Fewer visits may be important during the COVID-19 pandemic.
December 15, 2020
The monoclonal antibody medicine treats neuroblastoma in the bone and bone marrow.
FDA deemed Moderna’s vaccine candidate “highly effective,” so the agency may grant an emergency use authorization later this week.
December 08, 2020
After positive Phase 3 trial results, Karyopharm Therapeutics expects FDA to clear Xpovio.
The test is for patients to use at home, with a prescription, to detect both COVID-19 and influenza A and B.
December 01, 2020
FDA okayed the first drug for positron emission tomography (PET) imaging of prostate-specific membrane antigen positive lesions in men with prostate cancer.
The drug is the first FDA-approved therapy for these rare genetic diseases.
November 24, 2020
FDA official says the approval is important because of the combination of the flu season and the COVID-19 pandemic.
November 23, 2020
Regeneron's investigational treatment was administered to President Donald Trump in October when he was treated for COVID-19.
November 17, 2020
Merck earned a new indication for pembrolizumab (Keytruda), in combination with chemotherapy, to treat locally recurrent unresectable or metastatic triple-negative breast cancer (TNBC).
November 10, 2020
The investigational monoclonal antibody therapy bamlanivimab treats mild-to-moderate COVID-19 in adult and pediatric patients.
While Pfizer and BioNTech’s first interim analysis demonstrates the efficacy of their SARS-CoV-2 vaccine candidate, some questions remain.
November 03, 2020
Recalls of metformin products due to higher levels of the probable carcinogenic ingredient N-Nitrosodimethylamine (NDMA) than allowed continue.